The case for aggressive lipid regulation.
Lowering cholesterol levels with dietary or drug interventions lowers the risk for coronary heart disease (CHD) proportionately and reduced CHD morbidity and mortality, as well as overall mortality in patients with CHD. Antihyperlipidemic drugs are currently underused. Aggressive therapy is warranted for patients with established CHD. whose LDL cholesterol levels should be reduced to 100 mg/dL or lower.